Limited Competition: Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program

The Limited Competition Institutional Mentored Research Career Development Program for the Clinical and Translational Science Awards Program is administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Center for Advancing Translational Sciences. This program operates under the broader Clinical and Translational Science Award framework, which is a congressionally mandated initiative designed to accelerate the translation of scientific discoveries into clinical applications that improve patient outcomes and public health. The CTSA program supports a national network of academic medical centers by providing infrastructure, expertise, and collaborative opportunities necessary to move research findings from laboratory environments into real world healthcare settings. The primary purpose of this funding opportunity is to support institutional programs that foster the development of later stage postdoctoral researchers and junior faculty members who are committed to careers in clinical and translational science. These institutional career development programs are intended to provide structured mentorship, research training, and professional development opportunities that enable participants to achieve independence as investigators. By investing in this stage of the research pipeline, the program aims to ensure a sustained workforce capable of advancing translational science and addressing complex health challenges. Funding under this opportunity is provided as a grant and supports programmatic activities rather than individual fellowships. Allowable uses of funds generally include support for training infrastructure, mentorship programming, research development activities, and other institutional resources necessary to prepare scholars for independent research careers. While specific budgetary caps and floors are not detailed in the forecast, the funding is expected to align with NIH standards and regulatory frameworks outlined in federal regulations governing grant awards. There is no cost sharing or matching requirement associated with this opportunity, which lowers financial barriers for eligible institutions. Eligibility for this program is strictly limited and operates as a restricted competition. Only institutions that have successfully received awards under the Clinical and Translational Science Awards UM1 funding opportunity are eligible to apply. This means that applicants must already be part of the CTSA network or have demonstrated equivalent capacity through prior competitive selection. As a result, the applicant pool is confined to a defined group of academic and research institutions with established translational science infrastructure and demonstrated capability to manage complex federally funded programs. The application and submission process will follow standard NIH procedures once the full notice of funding opportunity is released. Applications will be submitted electronically and undergo a rigorous peer review process consistent with NIH guidelines. Reviewers will evaluate submissions based on scientific merit, program design, institutional capability, and the potential impact on the development of translational science careers. Only applications that are deemed meritorious through this process will be considered for funding, reinforcing the competitive and quality driven nature of the program. This opportunity is currently in a forecasted stage, with an estimated posting date in early September 2026 and an anticipated application deadline in mid February 2027. Awards are expected to be issued in December 2027, with project start dates aligned to the award date. The program operates on a federal fiscal year timeline and is expected to follow recurring cycles consistent with NIH funding practices, although explicit recurrence language is not provided. Institutions interested in applying should monitor official NIH communications and prepare in advance for the formal release of the funding announcement. For additional information or inquiries, applicants are directed to contact the Division of Clinical Innovation within the National Center for Advancing Translational Sciences via the provided program email address. This contact serves as the primary channel for questions related to eligibility, program requirements, and application preparation. Overall, this funding opportunity represents a strategic investment in the future of translational science by strengthening institutional capacity to train the next generation of independent researchers.

Ensure strong institutional mentorship structure and demonstrate capacity to advance translational research careers